Research output per year
Research output per year
Personal profile
Research interests
Medical oncology, treatment for breast cancer
Clinical interests
Medical oncology, treatment for breast cancer
Fingerprint
Dive into the research topics where Ashley Frith is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 9 Article
-
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
Ademuyiwa, F. O., Northfelt, D. W., O’Connor, T., Levine, E., Luo, J., Tao, Y., Hoog, J., Laury, M. L., Summa, T., Hammerschmidt, T., Guo, Z., Frith, A., Weilbaecher, K., Opyrchal, M., Aft, R., Clifton, K., Suresh, R., Bagegni, N., Hagemann, I. S., Iglesia, M. D., & 1 others, Dec 2023, In: npj Breast Cancer. 9, 1, 1.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis
Krishnamurthy, J., Luo, J., Suresh, R., Ademuyiwa, F., Rigden, C., Rearden, T., Clifton, K., Weilbaecher, K., Frith, A., Roshal, A., Tandra, P. K., Cherian, M., Summa, T., Haas, B., Thomas, S., Hernandez-Aya, L., Bergqvist, M., Peterson, L. & Ma, C. X., Dec 2022, In: npj Breast Cancer. 8, 1, 35.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography
Zhu, Q., Ademuyiwa, F. O., Young, C., Appleton, C., Covington, M. F., Ma, C., Sanati, S., Hagemann, I. S., Mostafa, A., Uddin, K. M. S., Grigsby, I., Frith, A. E., Hernandez-Aya, L. F. & Poplack, S. S., Aug 2021, In: Breast Cancer Research and Treatment. 188, 3, p. 615-630 16 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer
Ademuyiwa, F. O., Chen, I., Luo, J., Rimawi, M. F., Hagemann, I. S., Fisk, B., Jeffers, G., Skidmore, Z. L., Basu, A., Richters, M., Ma, C. X., Weilbaecher, K., Davis, J., Suresh, R., Peterson, L. L., Bose, R., Bagegni, N., Rigden, C. E., Frith, A., Rearden, T. P., & 14 others, Aug 2021, In: Breast Cancer Research and Treatment. 189, 1, p. 187-202 16 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations -
Interim analysis of the phase II study: Noninferiority study of doxorubicin with upfront dexrazoxane plus olaratumab for advanced or metastatic soft-tissue Sarcoma A C
van Tine, B. A., Hirbe, A. C., Oppelt, P., Frith, A. E., Rathore, R., Mitchell, J. D., Wan, F., Berry, S., Landeau, M., Heberton, G. A., Gorcsan, J., Huntjens, P. R., Soyama, Y., Vader, J. M., Alvarez-Cardona, J. A., Zhang, K. W., Lenihan, D. J. & Krone, R. J., Jul 15 2021, In: Clinical Cancer Research. 27, 14, p. 3854-3860 7 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations